Skip to main contentSkip to navigation
Sirius Investors
Global Bio-chem Technology Group Company Limited

Global Bio-chem Technology Group Company Limited

GBCMY
OTCBasic Materials

Global Bio-chem Technology Group Company Limited (GBCMY) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Global Bio-chem Technology Group Company Limited's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

P/E Ratio
4.64
Strong
WeakModerateStrong
P/B Ratio
-1.36
Equity Deficit
Earnings Yield
22.23%
Strong
WeakModerateStrong

Profitability Health

Return on Equity
-
No data
Operating Margin
-
No data
Net Profit Margin
-
No data

Growth Indicators

Revenue Growth
-
No data
Net Income Growth
-
No data
EPS Growth
-
No data

Efficiency & Liquidity

Current Ratio
-
No data
Quick Ratio
-
No data
Asset Turnover
-
No data
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

Free Cash Flow Yield
-4.04%
Weak
WeakModerateStrong
EV / Free Cash Flow
-84.61x
Strong
WeakModerateStrong
Net Debt / EBITDA
2.94x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
-
No data
Return on Invested Capital
-6.11%
Weak
WeakModerateStrong
Cash Conversion Cycle
-
No data

Fortress screener guardrails

0/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for GBCMY.

View Financial Statements